Has Reuben Gobezie, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,026,947 in general payments to Reuben Gobezie, MD across 414 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reuben Gobezie, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reuben Gobezie, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reuben Gobezie, MD

Orthopaedic Surgery · Cleveland, OHNPI 1295786770

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $11,614,173 of the $12,026,947 with a category attached, or 96.6%. Arthrex accounts for 100.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $2,658,969, 2.6 times the $1,027,576 reported in 2019. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,026,947in general payments, 2019–2025

Across 414 payments — averaging $29,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$12M
Zyla Life Sciences, Inc.$434
Pfizer$41
Smith+Nephew$18
Medline Industries LP$17
Johnson & Johnson$16
plus $28 from 2 others

$539,953in research payments, 2019–2025

Across 67 payments — averaging $8059.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$501K
Centinel Spine, LLC$39K

What the payments were for

Royalty or licence$11,614,17397%
Consulting fees$180,9042%
Speaking & faculty fees$216,8452%
Travel & lodging$9,3820%
Food & beverage$5,6440%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	364	$12,026,392
Zyla Life Sciences, Inc.	43	$434
Pfizer	2	$41
Smith+Nephew	1	$18
Medline Industries LP	1	$17
Johnson & Johnson	1	$16
Fidia Pharma USA Inc.	1	$15
Medtronic	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$48,358,773
SHOULDER SUTURE FIBERWIRE CERCLAGE$1,896,445
SHOULDER IMPLANTS BICEPS REPAIR BUTTON FIXATION$1,896,445
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$1,492,534
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$1,430,495
SHOULDER IMPLANTS OTHER PEC REPAIR$1,426,400
ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER MODULAR GLENOID SYSTEM$470,044
ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER REVERS$470,044
ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER UNIVERS$470,044
SHOULDER SUTURE FIBERWIRE #2 FIBERWIRE$7,560
KNEE & HIP SUTURE FIBERLOOP OTHER$7,560
ARTHROPLASTY INSTRUMENTS VIP TECHNOLOGY VIP 5D$3,150
SHOULDER IMPLANTS FIBERTAK KNOTLESS$630

How this compares

$12,026,947 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.

See all orthopaedic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$376,767

Medicare patients

661

Services billed

6,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisone	25	$148

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Cleveland

Wael BarsoumCleveland$8.9M
Joseph IannottiCleveland$7.1M
Anthony MiniaciCleveland$3.1M
Kenneth GreeneCleveland$2.6M
Mark FroimsonCleveland$2.5M
Robert MolloyCleveland$2.3M
Eric RicchettiCleveland$2.1M
Thomas MrozCleveland$1.3M
Robert GillespieCleveland$672K
George ThompsonCleveland$420K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →